Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alternatives to estrogen.

Lorraine A Fitzpatrick1

  • 1Endocrine Research Unit, Department of Endocrinology, Diabetes, Metabolism, Nutrition and Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. fitz@mayo.edu

The Medical Clinics of North America
|November 19, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erratum for Abaloparatide in Postmenopausal Women With Osteoporosis and Type 2 Diabetes: A Post Hoc Analysis of the ACTIVE Study.

JBMR plus·2021
Same author

Abaloparatide: an anabolic treatment to reduce fracture risk in postmenopausal women with osteoporosis.

Current medical research and opinion·2020
Same author

Abaloparatide followed by alendronate in women ≥80 years with osteoporosis: post hoc analysis of ACTIVExtend.

Menopause (New York, N.Y.)·2020
Same author

Abaloparatide in Postmenopausal Women With Osteoporosis and Type 2 Diabetes: A Post Hoc Analysis of the ACTIVE Study.

JBMR plus·2020
Same author

Cost-effectiveness of sequential treatment with abaloparatide followed by alendronate vs. alendronate monotherapy in women at increased risk of fracture: A US payer perspective.

Seminars in arthritis and rheumatism·2020
Same author

Response rates for hip, femoral neck, and lumbar spine bone mineral density in patients treated with abaloparatide followed by alendronate: Results from phase 3 ACTIVExtend.

Bone reports·2019
Same journal

Care Transitions Continue to Evolve.

The Medical clinics of North America·2026
Same journal

Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

The Medical clinics of North America·2026
Same journal

Care Transitions and Value-Based Payment Models in the United States.

The Medical clinics of North America·2026
Same journal

Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

The Medical clinics of North America·2026
Same journal

Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

The Medical clinics of North America·2026
Same journal

Social Determinants of Health: Unique Considerations in Transitions of Care.

The Medical clinics of North America·2026
See all related articles

Women seek alternative therapies for menopausal symptoms and overall health. This review examines the challenges, efficacy, and safety of alternative medicines, especially after the Women's Health Initiative findings.

Area of Science:

  • Integrative Medicine
  • Women's Health
  • Pharmacology

Background:

  • Growing interest in alternative therapies for menopausal symptoms and general well-being.
  • Increased demand for safe alternatives to conventional treatments, spurred by Women's Health Initiative findings.
  • Need for evidence-based evaluation of alternative medicine products.

Purpose of the Study:

  • To review the challenges and problems associated with alternative medicine use.
  • To assess the efficacy of alternative medicines through clinical trials.
  • To discuss potential safety issues related to alternative products.

Main Methods:

  • Literature review of clinical trials on alternative therapies.
  • Analysis of challenges in alternative medicine research.

Related Experiment Videos

  • Evaluation of safety data for commonly used alternative products.

    • Main Results:

    • Significant challenges exist in conducting rigorous clinical trials for alternative medicines.
    • Efficacy data for many alternative therapies remain limited or inconclusive.
    • Potential safety concerns and drug interactions are associated with some alternative products.

    Conclusions:

    • Further high-quality research is needed to establish the efficacy and safety of alternative therapies.
    • Healthcare providers must carefully consider the risks and benefits of alternative medicines for women's health.
    • Informed patient counseling is crucial regarding the use of alternative products for menopausal symptoms.